SMS Pharmaceuticals, a company in the Pharmaceuticals industry, reported revenue of ₹316 crore and net profit of ₹40 crore for the September 2026 quarter.
SMS Pharmaceuticals (NSE: SMSPHARMA) closed at ₹473.25 on 20 Nov 2026, up 66.7% over the past year. Its market capitalisation is ₹4,432 crore and it trades at 37.9 times earnings.
SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.